Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Neuromodulation start-up Saluda Medical completes $10mm Series B round

Executive Summary

Neuromodulation start-up Saluda Medical Pty. Ltd. (spinal cord stimulation (SCS) device for pain and other CNS diseases) completed a $10mm Series B round led by new investor Biosciences Managers, which was joined by existing investors. A 2013 spin-out from Australia's NICTA (Information Communications and Technology Research Centre of Excellence), the company will use the proceeds for conducting clinical trials and to fund commercialization efforts for its Evoke SCS system for chronic pain of the trunk and limbs.
Deal Industry
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies